| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/17/2008 | CN101322836A Formulation for improving bone metabolism |
| 12/17/2008 | CN101322835A Composite type formulation for replenishing calcium |
| 12/17/2008 | CN101322684A Acetic acid desmopressin injection prescription and preparation technique thereof |
| 12/17/2008 | CN100443501C Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/17/2008 | CN100443118C Dosages for treatment with anti-ErbB2 antibodies |
| 12/17/2008 | CN100443115C Granule with beauty and health function |
| 12/16/2008 | US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma |
| 12/16/2008 | US7465784 Antimicrobial peptides and methods of identifying the same |
| 12/16/2008 | US7465721 N-(10H-phenothiazin-2-ylcarbonyl)-L-leucyl-L-leucyl-N1-[(3 S)-2-methoxytetrahydrofuran-3-yl]-L-leucinamide; calpain (proteolytic enzyme) inhibitor; traps the reactive oxygen species ; antiinflammatory, antiproliferative agent, autoimmune diseases |
| 12/16/2008 | US7465714 Inhibit the growth or proliferation of tumor cells in vitro and in vivo, cancer therapy or diagnosis, inhibits lung and/or colorectal cancer cell growth |
| 12/16/2008 | US7465711 Treatment of cancers of lymphocytic cells with product R |
| 12/16/2008 | US7465710 Dipeptides and tripeptides; neuropeptide Y ("NPY") receptor antagonists and agonists |
| 12/16/2008 | US7465709 Structural formulas based on the repetitive motifs of salivary proline rich proteins mucin and collagen designed to modulate cell and tissue growth division and differentiation |
| 12/16/2008 | US7465708 Administering a branched polymer with a backbone of amino acid residues and at least one branch with at least 10 amino acid residues, wherein at least 38% of the amino acid residues are histidine and 10% of the amino acid residues are non-histidine; for treating bacteria, fungal, or viral infections |
| 12/16/2008 | US7465707 Methods of treatment with TR10 polypeptides |
| 12/16/2008 | US7465706 GDF3 propeptides and related methods |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/16/2008 | US7465704 Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF) |
| 12/16/2008 | US7465703 Evaluating samples before and after administering parathyroid hormone (PTH) for a PTH antagonist level |
| 12/16/2008 | US7465583 Comprising adeno-associated virus terminal repeat sequences; intrastrand base-pairing |
| 12/16/2008 | US7465572 De-immunized streptokinase |
| 12/16/2008 | US7465554 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof |
| 12/16/2008 | US7465551 Method of determining cytokine dosage for improving myelosuppressive state |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | US7465467 Process for the extraction, purification and enzymatic modification of soy 7S globulin α' subunit for use as hypocholesterolemizing agent |
| 12/16/2008 | US7465459 Piroplasmid vaccine |
| 12/16/2008 | US7465458 In situ administering Clostridium toxin; antiinflammatory agents |
| 12/16/2008 | US7465453 pharmaceutical composition containing a therapeutically effective amount of the CKLF1 C-terminal polypeptide used for treating the HIV infection, allergic disease, allograft rejection, diseases in brain and autoimmune diseases |
| 12/16/2008 | US7465452 Tumor antigen |
| 12/16/2008 | US7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 12/16/2008 | US7465450 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 12/16/2008 | US7465448 Chemokine receptor antagonists as therapeutic agents |
| 12/16/2008 | US7465447 Population of purified Fc-EPO fusion proteins for administration to mammal, proteins comprising Fc portion towards N-terminus and erythropoietin portion towards C-terminus, population having average of 11-28 sialic acid residues per purified Fc-EPO fusion protein; prolonged serum half-life; potency |
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465443 Acellular antibordetella vaccine |
| 12/16/2008 | US7465442 Reduction of dermal scarring |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | US7465321 Wet strength; treatingwith reducing agent ; crosslinking; extrusion; freeze drying |
| 12/16/2008 | US7465293 Syringe for inducing therapeutically-effective proteins |
| 12/16/2008 | CA2298018C Methods and compositions for inhibiting angiogenesis |
| 12/16/2008 | CA2295519C A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 12/16/2008 | CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/16/2008 | CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 12/16/2008 | CA2142678C Enteral composition comprising native micellar casein |
| 12/12/2008 | CA2634785A1 Enteric-coated glucosinolates and beta-thioglucosidases |
| 12/11/2008 | WO2008151306A1 Synthesis of cyclodepsipeptide compounds having antineoplastic and/or antimicrobial activity |
| 12/11/2008 | WO2008151257A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 12/11/2008 | WO2008151193A1 Compositions and methods for treating the vertebral column |
| 12/11/2008 | WO2008151037A1 Peptide-based stat inhibitor |
| 12/11/2008 | WO2008151035A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 12/11/2008 | WO2008150987A1 Novel basement membrane associated fibulin fragments that function as tumor suppressors with anti-angiogenic activity |
| 12/11/2008 | WO2008150981A2 Novel short peptides that inhibit the opening of mammalian tight junctions |
| 12/11/2008 | WO2008150929A1 Topical compositions comprising a macromolecule and methods of using same |
| 12/11/2008 | WO2008150896A2 P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH β-1 INTEGRIN ACTIVATION |
| 12/11/2008 | WO2008150868A1 Methods for inducing therapeutic t cells for immune diseases |
| 12/11/2008 | WO2008150821A1 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1) |
| 12/11/2008 | WO2008150689A1 Cyclic peptide cxcr4 antagonists |
| 12/11/2008 | WO2008150577A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | WO2008150509A1 Methods and compositions for treating spinal muscular atrophy |
| 12/11/2008 | WO2008150479A2 High temperature stable peptide formulation |
| 12/11/2008 | WO2008150444A1 Inhibition of hiv-1 infection by potent metallocene conjugated peptide through conformational entrapment of envelope gp120 |
| 12/11/2008 | WO2008150305A1 Intranasal carbetocin formulations and methods for the treatment of autism |
| 12/11/2008 | WO2008150282A1 Ribosomal s-6 kinase (rsk) inhibitory peptides and method of use thereof |
| 12/11/2008 | WO2008150275A2 Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection |
| 12/11/2008 | WO2008150196A1 Oxygen-transferring blood substitute |
| 12/11/2008 | WO2008150190A1 Compositions based on 2,6-di-tert-buthyl-4-methylphenol and a method for treating firearm wounds with the aid of said compositions |
| 12/11/2008 | WO2008150182A1 Compositions and methods for treatment of anthrax |
| 12/11/2008 | WO2008150181A1 Compositions and methods for treating anthrax exposure associated conditions |
| 12/11/2008 | WO2008150101A2 Chimeric polypeptide including a mussel adheisve protein and extracellular matrix |
| 12/11/2008 | WO2008150080A1 Injectable ready to use solutions comprising human chorionic gonadotropin |
| 12/11/2008 | WO2008150025A1 Novel bone mass increasing agent |
| 12/11/2008 | WO2008149782A1 Prognostic factor in sarcoma, and metastasis inhibitor |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008149428A1 Therapeutic agent and preventive agent for autoimmune disease, inflammation and nerve disease |
| 12/11/2008 | WO2008149374A1 Means and methods for enhancing weight gain in poultry |
| 12/11/2008 | WO2008149354A2 Agents for the treatment of inflammatory diseases and methods of using same |
| 12/11/2008 | WO2008149320A2 Slow release pharmaceutical composition made of microparticles |
| 12/11/2008 | WO2008149115A1 Precursor of tryptophyllin-1 and uses thereof |
| 12/11/2008 | WO2008148839A2 Long-acting polymeric prodrugs of exendin |
| 12/11/2008 | WO2008148751A1 Targeted induction of aggregation of proteins with cross beta structures |
| 12/11/2008 | WO2008148563A2 Viral latency model |
| 12/11/2008 | WO2008148545A1 Novel peptides and their use for the treatment of edema |
| 12/11/2008 | WO2008148463A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 12/11/2008 | WO2008148349A1 Use of beta-arrestin 1 for modulating t cell survival and autoimmunity |
| 12/11/2008 | WO2008148247A1 Cyclic analog of thymus pentapeptide, its preparing method and use |
| 12/11/2008 | WO2008148215A1 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | WO2008148170A1 Human metapneumovirus immunogenic peptides, compositions, and methods of use |
| 12/11/2008 | WO2008148166A1 Clostridial toxin netb |
| 12/11/2008 | WO2008148164A1 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences |
| 12/11/2008 | WO2008127419A3 Compositions and methods to increase the effect of a neurotoxin treatment |
| 12/11/2008 | WO2008124522A3 Amylin formulations |
| 12/11/2008 | WO2008118370A3 Hyperbaric treatment in wound healing |
| 12/11/2008 | WO2008118369A3 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity |
| 12/11/2008 | WO2008109712A3 Nanoparticle delivery systems for membrane-integrating peptides |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008109432A3 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 12/11/2008 | WO2008109401A3 Composition and method for treating papilloma virus and equine sarcoids |
| 12/11/2008 | WO2008109119A3 Wnt compositions and methods of use thereof |